Abstract: Poster Presentations |


Rafael Laniado-Laborin, MPH*
Author and Funding Information

Hospital General de Tijuana, Tijuana, Mexico


Chest. 2008;134(4_MeetingAbstracts):p130001. doi:10.1378/chest.134.4_MeetingAbstracts.p130001
Text Size: A A A
Published online


PURPOSE: To determine the extent of unaccounted expenses of antituberculosis treatment.

METHODS: One year (2007) cross-sectional study to 1. Assess the expenditure involved in tuberculosis diagnosis and treatment 2. Estimate the loss of working days and the consequential loss of income.

RESULTS: Eighty consecutive patients were interviewed; median age:35 years. They had been treated for a median of 4 months. Fifty (64%) were under directly observed therapy (DOT), 20 (26%)under self-administered treatment (SAT), and 8 (10%) initially under DOT and later under SAT. DOT was administered at the health center in 58% of the cases and at home in 42%. It was supervised by health personnel in 87.5% of the cases. Median time to get to the health center was 60 minutes. Forty-eight traveled by bus (65.7%) and 20 (25%) walked to the health center. Patients required 2.4±1.3 bus trips with a median cost of 18 pesos (exchange rate:1 US=11 pesos). For patients under DOT at the health center this would amount up to $360 pesos each month (approximately 10% of their income). Twenty-nine (36.3%) had to buy some medication during treatment, most commonly antituberculosis drugs(48.2%)and 57 (71.2%) had to pay for some of their diagnostic studies (median $500 pesos). Of those that had personal earnings, 33 (56%) earned 1,000 pesos or less per week and 20 (34%) earned $1,000–2,000 pesos per week. Fifty of them (85%) were unable to work due to illness, 90% of them for at least one month (three or more months in 54% of the cases). Patients under health center DOT had to miss or arrive late at work on a daily basis. Fifty-six patients (70%) had no medical insurance or medical coverage.

CONCLUSION: Important unaccounted costs include transportation expenditures, cost of diagnostic studies, complementary medications and lost income.

CLINICAL IMPLICATIONS: Unaccounted costs may constitue a barrier for treatment success. Interventions that reduce the number of health encounters and travel distances are needed.

DISCLOSURE: Rafael Laniado-Laborin, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 29, 2008

1:00 PM - 2:15 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
The cursed duet today: Tuberculosis and HIV-coinfection. Presse Med 2017;46(2 Pt 2):e23-e39.
Presse Med 2017;46(2 Pt 2):e41-e51.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543